全文获取类型
收费全文 | 41611篇 |
免费 | 2003篇 |
国内免费 | 177篇 |
专业分类
耳鼻咽喉 | 541篇 |
儿科学 | 837篇 |
妇产科学 | 467篇 |
基础医学 | 5178篇 |
口腔科学 | 1265篇 |
临床医学 | 2799篇 |
内科学 | 9850篇 |
皮肤病学 | 819篇 |
神经病学 | 3778篇 |
特种医学 | 2069篇 |
外国民族医学 | 1篇 |
外科学 | 6477篇 |
综合类 | 144篇 |
一般理论 | 6篇 |
预防医学 | 1259篇 |
眼科学 | 849篇 |
药学 | 2734篇 |
中国医学 | 78篇 |
肿瘤学 | 4640篇 |
出版年
2023年 | 235篇 |
2022年 | 436篇 |
2021年 | 741篇 |
2020年 | 434篇 |
2019年 | 558篇 |
2018年 | 717篇 |
2017年 | 609篇 |
2016年 | 744篇 |
2015年 | 748篇 |
2014年 | 938篇 |
2013年 | 1182篇 |
2012年 | 1928篇 |
2011年 | 2050篇 |
2010年 | 1236篇 |
2009年 | 1066篇 |
2008年 | 1840篇 |
2007年 | 2111篇 |
2006年 | 1967篇 |
2005年 | 1872篇 |
2004年 | 1905篇 |
2003年 | 1844篇 |
2002年 | 1823篇 |
2001年 | 1377篇 |
2000年 | 1464篇 |
1999年 | 1324篇 |
1998年 | 547篇 |
1997年 | 463篇 |
1996年 | 408篇 |
1995年 | 351篇 |
1994年 | 339篇 |
1993年 | 326篇 |
1992年 | 1020篇 |
1991年 | 873篇 |
1990年 | 849篇 |
1989年 | 826篇 |
1988年 | 787篇 |
1987年 | 770篇 |
1986年 | 681篇 |
1985年 | 641篇 |
1984年 | 434篇 |
1983年 | 355篇 |
1979年 | 303篇 |
1978年 | 210篇 |
1977年 | 180篇 |
1974年 | 193篇 |
1973年 | 164篇 |
1972年 | 163篇 |
1971年 | 184篇 |
1970年 | 157篇 |
1969年 | 178篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
We reported movement-related cortical potentials (MRCPs) in 11 patients with lesion of the dentate nucleus (Machado-Joseph disease (MJD) 7 cases, dentato-rubro-pallido-luysian atrophy (DRPLA)1, myoclonus epilepsy associated with ragged-red fibers (MERRF)1, dyssynergia cerebellaris myoclonica (DCM) 2), and compared with those of 7 cases of multiple system atrophy (MSA) who were postulated to have mild dentate lesions (striato-nigral degeneration 2 cases, Shy-Drager syndrome 2, sporadic olivo-ponto-cerebellar atrophy 3), and 7 control subjects without any neurological findings. Further we classified the diseases into the following two groups based on the lesion of the dentate nucleus. One was MJD group that had normal or slightly abnormal electroencephalogram (EEG), and the other was DN group (DRPLA, MERRF, DCM) that had markedly abnormal EEG. One of the main findings from this study was smaller slope of the Ns' in the MJD and DN group and normal slope of BP. There was no significant difference in the slope of Ns' between MJD patients and DN patients. This result shows EEG abnormalities have no influence on MRCP recordings. These results suggest that Ns' component may reflect the function in the cerebellar dentate nucleus, and that MRCP is a useful diagnostic method in patients with cerebellar ataxia. 相似文献
72.
W A Gomes F A Lado N C de Lanerolle K Takahashi C Pan H P Hetherington 《Magnetic resonance in medicine》2007,58(2):230-235
Reduced hippocampal N-acetyl aspartate (NAA) is commonly observed in patients with advanced, chronic temporal lobe epilepsy (TLE). It is unclear, however, whether an NAA deficit is also present during the clinically quiescent latent period that characterizes early TLE. This question has important implications for the use of MR spectroscopic imaging (MRSI) in the early identification of patients at risk for TLE. To determine whether NAA is diminished during the latent period, we obtained high-resolution (1)H spectroscopic imaging during the latent period of the rat pilocarpine model of human TLE. We used actively detuneable surface reception and volume transmission coils to enhance sensitivity and a semiautomated voxel shifting method to accurately position voxels within the hippocampi. During the latent period, 2 and 7 d following pilocarpine treatment, hippocampal NAA was significantly reduced by 27.5 +/- 6.9% (P < 0.001) and 17.3 +/- 6.9% (P < 0.001) at 2 and 7 d, respectively. Quantitative estimates of neuronal loss at 7 d (2.3 +/- 7.7% reduction; P = 0.58, not significant) demonstrate that the NAA deficit is not due to neuron loss and therefore likely represents metabolic impairment of hippocampal neurons during the latent phase. Therefore, spectroscopic imaging provides an early marker for metabolic dysfunction in this model of TLE. 相似文献
73.
Masahito Minakawa Kenji Takahashi Norihiro Kondo Masaharu Hatakeyama Toshihiko Kuga Ikuo Fukuda 《The Japanese Journal of Thoracic and Cardiovascular Surgery》2003,51(11):582-587
Objective: Reoperative coronary bypass grafting is at high risk. Particularly in redo cases where the patent graft is running near
the midline of the sternum, the graft may be exposed to injury by a median sternotomy and subsequent dissection. Whereas,
off-pump bypass grafting from the left axillary artery or descending thoracic artery by a left thoracotomy approach is safe
for preventing graft damage.Methods: From March 1998 to February 2002, we performed off-pump coronary artery bypass grafting by a left thoracotomy approach in
9 patients. The left axillary artery was used as the inflow vessel in 4 cases, and the descending thoracic, aorta in 5.Results: The radial artery was anastomosed proximally to the axillary artery in 4 cases and the descending thoracic aorta in one
case. The saphenous vein graft was anastomosed, proximally to the descending thoracic aorta in 4 cases. Transdiaphragmatic
minimally invasive bypass grafting for the right coronary artery was simultaneously performed in 3 cases. Postoperative cardiac
events were ventricular arrhythmia in 6 cases and supraventricular arrhythmia in 3 cases. There was no damage to the patent
grafts. Postoperative coronary angiography performed, in 8 cases revealed all the grafts to be patent without stenosis. Cardiac
symptoms were not found after the operation in any of the cases.Conclusions: These procedures can prevent the injury to patent grafts caused by a median sternotomy, and will be one of the useful strategies
for reoperative off-pump coronary artery bypass grafting. 相似文献
74.
75.
76.
Increased 5-HT-2 receptor function as measured by serotonin-stimulated phosphoinositide hydrolysis in platelets of depressed patients. 总被引:2,自引:0,他引:2
M Mikuni I Kusumi A Kagaya Y Kuroda H Mori K Takahashi 《Progress in neuro-psychopharmacology & biological psychiatry》1991,15(1):49-61
1. The present study was undertaken to examine whether or not 5-HT-induced inositol monophosphate (IP-1) accumulation in human platelets is mediated by 5-HT-2 receptors and to assess 5-HT-2 receptor function as measured by 5-HT-stimulated IP-1 accumulation in platelets from normal controls and depressed patients before drug treatment. 2. In platelets prelabeled with 3H-myo-inositol, in Ca ion free HEPES buffer containing 10 mM LiCl, 5-HT caused a dose-dependent accumulation of IP-1 during 15 min incubation. A maximal increase in IP-1 formation was observed at 30 microM of 5-HT and its EC50 value was 4 microM. 3. Ketanserin, a selective 5-HT-2 antagonist, was a potent inhibitor of 5-HT-stimulated IP-1 accumulation with a Ki value of 12 nM, but (-)propranolol (10 microM), a 5-HT-1 antagonist, failed to block the 5-HT response. 4. The potencies of various compounds tested to inhibit 5-HT-stimulated IP-1 accumulation in human platelets correlated positively with the affinities to 5-HT-2 receptor as defined by radioligand binding in rat cerebral cortex. 5. In a group of unmedicated patients with major depressive disorder matched for age with normal control group, we found a significant increase in 5-HT (100 microM)-induced accumulation of IP-1 (150 +/- 7% of basal for depressed patients, 132 +/- 3% for controls). 相似文献
77.
78.
79.
80.
T Someya M Shibasaki T Noguchi S Takahashi T Inaba 《Journal of clinical psychopharmacology》1992,12(3):169-174
In 39 patients who received haloperidol regularly we measured plasma concentrations of haloperidol glucuronide (HAL-GL), reduced haloperidol glucuronide (RHAL-GL), haloperidol (HAL), reduced haloperidol (RHAL), and HAL reductase activity in red blood cells. Plasma HAL-GL concentrations were significantly higher than HAL, RHAL, or RHAL-GL concentrations. Concentration ratios of total glucuronide to nonglucuronide and RHAL/HAL ratios were calculated as indices of glucuronidation and reduction capacity in each patient. The plasma glucuronidation ratios showed a significant negative correlation (r = -0.63, p less than 0.001) with the dose, while the reduction ratios showed a positive correlation (r = 0.75, p less than 0.001). No correlations were found between the HAL reductase activity in red blood cells and either the dose or RHAL/HAL. Based on these findings we suggest that glucuronidation of HAL is the major metabolic pathway of HAL in humans and its activity is important in determining steady-state plasma HAL concentrations. Glucuronidation may also be a major contributing factor in the interindividual variability of HAL metabolism. 相似文献